Prof. Hamdy A. Azim HER2-positive Metastatic Breast Cancer Wrap-up 2/2

Prof. Hamdy A. Azim HER2-positive Early Breast Cancer Wrap-upПодробнее

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02Подробнее

Prof. Hamdy A. Azim HER2-positive Metastatic Breast Cancer Wrap-up 1/2Подробнее

Poziotinib for HER2-positive metastatic breast cancerПодробнее

Case Study: HER2-Positive Oligometastatic Breast CancerПодробнее

Dual HER2 blockade in patients with HER2-positive breast cancer after pCRПодробнее

Current and future HER2+, HR- metastatic breast cancer treatment approachesПодробнее

Part 2-Management of metastatic breast cancer:luminal and her 2 positive tumors- Prof. Gilles FreyerПодробнее

HER2 Positive (HER2+) Metastatic Breast CancerПодробнее

Managing Central Nervous System Metastasis in Patients With HER2-Positive Breast CancerПодробнее

First-Line Treatment of HER2-Positive Metastatic Breast CancerПодробнее

Management of HER2 positive metastatic breast cancer treatment algorithmПодробнее

Updates in the management of HER2 positive Breast CancerПодробнее

ENHERTU - what it is and how it works #breastcancerПодробнее

Selecting and Sequencing of HER2-Targeting Therapies in HER2-Positive Metastatic Breast CancerПодробнее

Breast Cancer Treatment Part 2Подробнее

Dr. Geyer Discusses Challenges in HER2-Positive Metastatic Breast Cancer ManagementПодробнее

Oncology Today with Dr Neil Love — HER2-Positive Metastatic Breast CancerПодробнее